4.2 Letter

Lingual CD36 and obesity: A matter of fat taste?

期刊

ACTA HISTOCHEMICA
卷 113, 期 7, 页码 765-767

出版社

ELSEVIER GMBH
DOI: 10.1016/j.acthis.2010.10.004

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Correction Oncology

5-Aza-2′-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy (vol 142, pg 1370, 2014)

Malgorzata Wachowska, Magdalena Gabrysiak, Angelika Muchowicz, Weronika Bednarek, Joanna Barankiewicz, Tomasz Rygiel, Louis Boon, Pawel Mroz, Michael R. Hamblin, Jakub Golab

EUROPEAN JOURNAL OF CANCER (2021)

Article Allergy

ARGX-117, a therapeutic complement inhibiting antibody targeting C2

Inge Van de Walle, Karen Silence, Kevin Budding, Liesbeth Van de Ven, Kim Dijkxhoorn, Elisabeth de Zeeuw, Cafer Yildiz, Sofie Gabriels, Jean-Michel Percier, Johanna Wildemann, Jan Meeldijk, Peter J. Simons, Louis Boon, Linda Cox, Rob Holgate, Rolf Urbanus, Henny G. Otten, Jeanette H. W. Leusen, Christophe Blanchetot, Hans de Haard, C. Erik Hack, Peter Boross

Summary: ARGX-117 is a promising new complement inhibitor that uniquely targets both the classical and lectin pathways by binding to the Sushi-2 domain of C2. It prevents complement-mediated cytotoxicity in in vitro models for autoimmune hemolytic anemia and antibody-mediated rejection of organ transplants.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Immunology

Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation

Xiaofei Xu, Errol Prens, Edwin Florencia, Pieter Leenen, Luis Boon, Patrick Asmawidjaja, Anne-Marie Mus, Erik Lubberts

Summary: The up-regulation of IL-19 and IL-24 induced by IL-17A in skin stromal cells contributes to keratinocyte proliferation. Depletion of IL-10 leads to increased expression of IL-23/IL-17 pathway related cytokines followed by significant up-regulation of IL-19 and IL-24.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma

Mary Frances Wedekind, Katherine E. Miller, Chun-Yu Chen, Pin-Yi Wang, Brian J. Hutzen, Mark A. Currier, Brooke Nartker, Ryan D. Roberts, Louis Boon, Joe Conner, Stephanie LaHaye, Benjamin J. Kelly, David Gordon, Peter White, Elaine R. Mardis, Timothy P. Cripe

Summary: In murine osteosarcoma models, there were divergent responses to immunotherapy, with mice bearing K7M2 showing better survival outcomes with combination therapy. K7M2 exhibited higher expression of immune-related genes and immune cell infiltrates compared to F420.

ISCIENCE (2021)

Article Cardiac & Cardiovascular Systems

Interleukin-23 receptor expressing γδ T cells locally promote early atherosclerotic lesion formation and plaque necrosis in mice

Jesus Gil-Pulido, Nuria Amezaga, Ivana Jorgacevic, Helga D. Manthey, Melanie Roesch, Theresa Brand, Peter Cidlinsky, Sarah Schafer, Andreas Beilhack, Antoine-Emmanuel Saliba, Kristina Lorenz, Louis Boon, Immo Prinz, Ari Waisman, Thomas Korn, Clement Cochain, Alma Zernecke

Summary: IL-23R(+) gamma delta T cells predominantly found in the aortic root promote early atherosclerotic lesion formation, plaque necrosis, and inflammation at this site. Targeting IL-23R may be explored as a therapeutic approach to mitigate atherosclerotic lesion development.

CARDIOVASCULAR RESEARCH (2022)

Article Immunology

Intestinal helminth infection transforms the CD4+ T cell composition of the skin

Cajsa H. Classon, Muzhen Li, Ada Lerma Clavero, Junjie Ma, Xiaogang Feng, Christopher A. Tibbitt, Julian M. Stark, Rebeca Cardoso, Emma Ringqvist, Louis Boon, Eduardo J. Villablanca, Antonio Gigliotti Rothfuchs, Liv Eidsmo, Jonathan M. Coquet, Susanne Nylen

Summary: Infection by strictly intestinal helminths can increase the numbers of CD4(+) T cells in the skin of mice, leading to a skewed T(H)2 cell composition and long-term effects on skin immune responses. This indicates a novel gut-to-skin cell trafficking process and worm-mediated immunosuppression.

MUCOSAL IMMUNOLOGY (2022)

Article Biology

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology

Riem Gawish, Philipp Starkl, Lisabeth Pimenov, Anastasiya Hladik, Karin Lakovits, Felicitas Oberndorfer, Shane J. F. Cronin, Anna Ohradanova-Repic, Gerald Wirnsberger, Benedikt Agerer, Lukas Endler, Tumay Capraz, Jan W. Perthold, Domagoj Cikes, Rubina Koglgruber, Astrid Hagelkruys, Nuria Montserrat, Ali Mirazimi, Louis Boon, Hannes Stockinger, Andreas Bergthaler, Chris Oostenbrink, Josef M. Penninger, Sylvia Knapp

Summary: Despite progress in understanding COVID-19, limited mechanistic insight into immunological factors and disease severity remains. Scientists generated a mouse-adapted SARS-CoV-2 strain, maVie16, and found that cytokine-driven immunopathology and ACE2 dependence determine disease severity. This study provides a new tool for discovering therapies.
Article Immunology

Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1

Saskia V. Vijver, Akashdip Singh, Eline T. A. M. Mommers-Elshof, Jan Meeldijk, Ronald Copeland, Louis Boon, Sol Langermann, Dallas Flies, Linde Meyaard, M. Ines Pascoal Ramos

Summary: The tumor microenvironment contains collagen fragments that can mediate T cell suppression through LAIR-1, leading to poor outcomes in cancer patients with high expression levels of MMPs and LAIR-1. Therapeutic strategies targeting the interaction of LAIR-1 with collagen fragments may help to reverse T cell dysfunction and improve immunity in cancer patients.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

Jenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, Daniel M. Borras, Yani Berckmans, Roxanne Wouters, Raquel S. Laureano, Thais Baert, Louis Boon, Chiara Landolfo, Antonia Carla Testa, Daniela Fischerova, Caroline Van Holsbeke, Tom Bourne, Valentina Chiappa, Wouter Froyman, Dominique Schols, Patrizia Agostinis, Dirk Timmerman, Sabine Tejpar, Ignace Vergote, An Coosemans, Abhishek D. Garg

Summary: The study established a novel biomarker resource for serum screening in patients with ovarian cancer to evaluate peripheral immunodynamics, patient survival trends, malignancy risk, and preclinical chemo-immunotherapy strategies. The in silico data-driven framework predicted that analysis of myeloid NF kappa B signaling and interferon-stimulated genes' responses could capture patients' peripheral immunodynamics effectively. Multiparametric serum profiling of patients with ovarian cancer showed that the sFIS assay can decode peripheral immunology, estimate survival trends, and co-estimate malignancy risk.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Cell Biology

Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse

Gaurang Jhala, Balasubramanian Krishnamurthy, Thomas C. Brodnicki, Tingting Ge, Satoru Akazawa, Claudia Selck, Prerak M. Trivedi, Evan G. Pappas, Leanne Mackin, Nicola Principe, Erwan Bremaud, David J. De George, Louis Boon, Ian Smyth, Jonathan Chee, Thomas W. H. Kay, Helen E. Thomas

Summary: IFN gamma regulates the expansion of antigen-specific CD8(+) T cells by controlling the expression of SOCS-1. Despite reduced inflammation in Ifngr-mutant mice, the expanded CD8(+) T cells may contribute to normal diabetes progression.

CELL REPORTS (2022)

Article Immunology

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations

Nicola Principe, Wayne J. Aston, Danika E. Hope, Caitlin M. Tilsed, Scott A. Fisher, Louis Boon, Ian M. Dick, Wee Loong Chin, Alison M. McDonnell, Anna K. Nowak, Richard A. Lake, Jonathan Chee, Willem Joost Lesterhuis

Summary: This study investigated the combination effects of various chemotherapies with immune checkpoint blockade (ICB) and identified chemotherapy/ICB combinations that showed additive or non-additive effects. The combination of 5-fluorouracil (5-FU) or cisplatin with ICB had additive effects, while vinorelbine and etoposide did not provide additional benefit when combined with ICB. Furthermore, the study found that the combination of 5-FU with ICB increased inflammation in the tumor microenvironment, which may contribute to its effective combination therapy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy

Peter Rose, Natasja K. van den Engel, Julia R. Kovacs, Rudolf A. Hatz, Louis Boon, Hauke Winter

Summary: Depleting antibodies targeting myeloid-derived suppressor cells (MDSC) enhance the induction of tumor-specific T cells and delay the growth of melanoma.

VACCINES (2022)

Article Immunology

Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication

Marco Gargaro, Giulia Scalisi, Giorgia Manni, Carlos G. Briseno, Prachi Bagadia, Vivek Durai, Derek J. Theisen, Sunkyung Kim, Marilena Castelli, Chenling A. Xu, Gerd Meyer zu Horste, Giuseppe Servillo, Maria A. Della Fazia, Giulia Mencarelli, Doriana Ricciuti, Eleonora Padiglioni, Nicola Giacche, Carolina Colliva, Roberto Pellicciari, Mario Calvitti, Teresa Zelante, Dietmar Fuchs, Ciriana Orabona, Louis Boon, Alban Bessede, Marco Colonna, Paolo Puccetti, Theresa L. Murphy, Kenneth M. Murphy, Francesca Fallarino

Summary: This study identifies a previously unrecognized metabolic communication pathway, in which cDC1 cells extend their immunoregulatory capacity to cDC2 through the production of L-kynurenine. This finding has potential therapeutic implications in treating autoimmune demyelinating diseases.

IMMUNITY (2022)

Article Multidisciplinary Sciences

Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy

Ashleigh R. Poh, Christopher G. Love, David Chisanga, James H. Steer, David Baloyan, Michael Chopin, Stephen Nutt, Jai Rautela, Nicholas D. Huntington, Nima Etemadi, Megan O'Brien, Ryan O'Keefe, Lesley G. Ellies, Christophe Macri, Justine D. Mintern, Lachlan Whitehead, Gangadhara Gangadhara, Louis Boon, Ashwini L. Chand, Clifford A. Lowell, Wei Shi, Fiona J. Pixley, Matthias Ernst

Summary: Genetic ablation or therapeutic inhibition of the myeloid-specific hematopoietic cell kinase (HCK) enhances the response to immunotherapy by modifying the tumor microenvironment and promoting immune cell activation.

SCIENCE ADVANCES (2022)

Article Immunology

Peribronchial Inflammation Resulting from Regulatory T Cell Deficiency Damages the Respiratory Epithelium and Disturbs Barrier Function

Anne -Charlotte Jonckheere, Brecht Steelant, Sven F. Seys, Jonathan Cremer, Ellen Dilissen, Louis Boon, Adrian Liston, Rik Schrijvers, Christine Breynaert, Jeroen A. J. Vanoirbeek, Jan L. Ceuppens, Dominique M. A. Bullens

Summary: This study investigates the role of regulatory T cells (Tregs) in maintaining the epithelial barrier and controlling tight junction expression. The results show that Treg deficiency leads to airway inflammation and decreased tight junction expression. Treatment with CTLA4-Ig effectively prevents barrier dysfunction and suppresses inflammation and cytokine secretion. Neutralization of IL-4 partially reverses the effects of Treg depletion, while neutralization of IL-6 and IFN-g has limited effects.

JOURNAL OF IMMUNOLOGY (2022)

Article Cell Biology

BrdU does not induce hepatocellular damage in experimental Wistar rats

Abril Alondra Barrientos-Bonilla, Paola Belem Pensado-Guevara, Abraham Puga-Olguin, Rasajna Nadella, Aurora del Carmen Sanchez-Garcia, Laura Mireya Zavala-Flores, Arnulfo Villanueva-Olivo, Iliana Tamara Cibrian-Llanderal, Maria de Jesus Rovirosa-Hernandez, Daniel Hernandez-Baltazar

Summary: This study evaluated the impact of BrdU on liver function and found that multiple injections of BrdU did not induce hepatocellular damage.

ACTA HISTOCHEMICA (2024)

Article Cell Biology

Catalpol antagonizes LPS-mediated inflammation and promotes osteoblast differentiation through the miR-124-3p/DNMT3b/TRAF6 axis

Pan Zhang, Qun Feng, Wenxiao Chen, Xizhuang Bai

Summary: It was found that catalpol antagonizes LPS-mediated inflammation and suppressive osteoblast differentiation by inhibiting inflammation and promoting osteoblast differentiation. This finding contributes to a better understanding of the pathogenesis of osteoporosis.

ACTA HISTOCHEMICA (2024)